Episode Appearances
Biotech Hangout · May 8, 2026
Episode 182 - May 8, 2026
“Disagreed with staff decision to approve Sanofi's tiblizumab; withdrew drug from Commissioner's Voucher program”
Biotech Secondary Capital Raises and Market SaturationFDA Regulatory Uncertainty and Commissioner McCary LeadershipM&A Activity in Biotech and Venture Capital Returns
View Analysis
DarkHorse Podcast · Jan 17, 2026
The Washington State of Science: The 309th Evolutionary Lens with Bret Weinstein and Heather Heying
“Co-author of CDC assessment comparing U.S. childhood vaccine schedule to peer nations; described as cautious institutional figure”
Childhood Vaccine Schedule ReformFederal vs. State Health Authority ConflictsCOVID-19 Vaccine Safety and Efficacy
View Analysis
All-In with Chamath, Jason, Sacks & Friedberg · Jan 15, 2026
Can We Trust the FDA? Marty Makary on Science, Power & Patients
FDA drug approval reformVaccine schedule modificationsFood pyramid restructuring
View Analysis